N-Acetylcysteine and Blood Loss in Cardiac Surgery
Author Information
Author(s): Wesner Amber R., Brackbill Marcia L., Sytsma Christine S.
Primary Institution: Winchester Medical Center
Hypothesis
Does preoperative exposure to n-acetylcysteine increase postoperative blood loss in cardiac surgery patients?
Conclusion
Preoperative exposure to NAC did not increase postoperative blood loss or negatively affect other bleeding parameters.
Supporting Evidence
- Patients treated with NAC lost less blood in the first 24 hours after surgery than those who did not receive NAC.
- No significant differences were observed in blood loss between groups at 48 and 72 hours.
- NAC did not negatively affect prothrombin time, hemoglobin, hematocrit, or platelet counts.
Takeaway
This study looked at whether a medicine called NAC affects how much blood patients lose after heart surgery. It found that NAC actually helped patients lose less blood in the first day after surgery.
Methodology
Retrospective review of cardiac surgery patients who received NAC versus those who did not, measuring blood loss at 24, 48, and 72 hours post-surgery.
Potential Biases
Potential bias due to incomplete documentation in medical records.
Limitations
The study was retrospective, had a small sample size, and differences in baseline characteristics between groups.
Participant Demographics
Patients were >18 years old, with a history of diabetes and hypertension more common in the NAC group.
Statistical Information
P-Value
0.04
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website